RSS Amplifier

Makis Health - by William Makis (Cancer Researcher) · Aug 20, 2026

NEWS: Moderna stock goes up 160% on “fluff nonsense” about an mRNA Cancer Vaccine

0
Sign in to vote or save

William Makis · Makis Health - by William Makis (Cancer Researcher)

Imagine buying Moderna MRNA 0.00%↑ after it’s gone up 160%, not knowing that:

1.

The first person in the world who took Moderna’s mRNA-4157 Cancer vaccine outside of Clinical Trials died recently with no improvement - he was a jabbed Australian Cancer Researcher (@ProfRAScolyer)

2. Moderna’s mRNA Cancer Vaccine is actually

18 to 27 injections (Phase 2 had 27 injections, Phase 3 had 18)

3. Moderna’s mRNA Cancer Vaccine has an upto

36% severe side effect rate (Grade 3+)

4.

Moderna didn’t actually give us any results of their Phase 3 INTerpath-001 Trial and Phase 2 results were underwhelming at best

5.

Merck actually takes 50% of the profit of every Moderna mRNA Cancer Vaccine sold

This was a Big Pharma bot driven news day with no substance whatsoever.

If you bought low, this was an excellent

dead cat bounce as far as a stock move is concerned, but that’s all this is.There is no “cure for cancer” here, sorry to say

Give a gift subscription

Share

Read the original on makisw.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.